Treating chronic myeloid leukemia in the era of tyrosine kinase inhibitors

Acta Haematol. 2013;130(3):192-5. doi: 10.1159/000351957. Epub 2013 Jun 13.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Humans
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive / drug therapy*
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive / enzymology
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive / genetics
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive / pathology
  • Protein Kinase Inhibitors / therapeutic use*

Substances

  • Protein Kinase Inhibitors